OBIO vs PAYC · rev $198.0K vs P/E 33, rev $1.10B
Orchestra BioMed Holdings Inc. (OBIO) versus Paycom Soft (PAYC) — a side-by-side from cached financials, not a winner call.
Orchestra BioMed Holdings Inc. (OBIO) is a biotechnology company listed on NASDAQ.
Paycom Soft (PAYC) is a software - application company listed on US.
Latest reported OBIO revenue for 2026-06-30 was $198.0K. Net income was -$44.4M. Revenue was up 80.0% from 2026-03-31 to 2026-06-30. OBIO currently screens at market cap $231.7M.
Latest reported PAYC revenue for 2026-06-30 was $1.10B. Net income was $263.1M. Revenue was up 92.9% from 2026-03-31 to 2026-06-30. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
OBIO currently screens at market cap $231.7M. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
Not investment advice. Open the OBIO and PAYC stock pages for the full models.
Not investment advice.